97
Cardiac Medications: What’s With the Mixing & Matching? Michele B. Collins MSN RN CCRN September 2009

Cardiac medications nursing review 2011

  • View
    5.709

  • Download
    0

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Cardiac medications nursing review 2011

Cardiac Medications: What’s With the Mixing &

Matching?

Michele B. Collins MSN RN CCRNSeptember 2009

Page 2: Cardiac medications nursing review 2011
Page 3: Cardiac medications nursing review 2011

Sodium-Potassium PumpSodium OUTSIDE cell & Potassium INSIDE cell before depolarization

Cell has NEGATIVE charge & must CONTRACT to become POSITIVE

SA node has less negativity so it serves as pacemaker

Page 4: Cardiac medications nursing review 2011

• With cell stimulation, cell permeability allows sodium INTO cell & potassium OUT of cell

• With sodium, can only have STAT (“fast channel”) contraction

• Calcium (“fast channel”) also enters cell, leading to total controlled contraction

Page 5: Cardiac medications nursing review 2011

Cardiac Repolarization

• Na+ - K+ pump uses energy (ATP) so SODIUM LEAVES cell and POTASSIUM RETURNS to cell

• Calcium also leaves cell at this time

Page 6: Cardiac medications nursing review 2011

Cardiac Repolarization

If the S-A node does not generate an impulse, another cardiac site WILL (“reentry phenomenon”)

Page 7: Cardiac medications nursing review 2011

Statistically, if you take six different drugs, you have an80% percent chance of at leastone drug-drug interaction.

Wayne K. Anderson, Dean,State University of New YorkSchool of Pharmacy

Page 8: Cardiac medications nursing review 2011

Medications Discussed

• Antiarrhythmics• Beta Blockers Ace Inhibitors • Calcium Channel Blockers • ACE Inhibitors• Angiotensin II Receptor Blockers (ARB)• Diuretics• Digitalis• Nitrates• Amiodarone

Page 9: Cardiac medications nursing review 2011

Why so Many?

• In atrial fibrillation, used to suppress arrhythmias

• Often done to relieve the symptoms associated with loss of the atrial component to ventricular filling (atrial kick) due to atrial fibrillation or flutter.

Page 10: Cardiac medications nursing review 2011

• In individuals with ventricular arrhythmias, used to suppress arrhythmias. Antiarrhythmic agents may be considered the first-line therapy in the prevention of sudden death in certain forms of structural heart disease

Page 11: Cardiac medications nursing review 2011
Page 12: Cardiac medications nursing review 2011

Automaticity• Refers to a cardiac muscle cell firing off

an impulse on its own• All cardiac cells can initiate an

action potential, however, only some of these cells are designed to routinely trigger heart beats

• Found in the 'conduction system' of the heart and include the SA node, AV node, Bundle of HIS and Purkinje fibers

• Sinoatrial node is a single specialized location in the atrium which has a higher automaticity (a faster pacemaker) than the rest of the heart, and therefore is usually responsible for setting the heart rate, and initiating each heart beat.

Page 13: Cardiac medications nursing review 2011

Re-entry• Occurs when an electrical

impulse recurrently travels in a tight circle within the heart, rather than moving from one end of the heart to the other and then stopping

• If conduction is abnormally slow in some areas, part of the impulse will arrive late and potentially be treated as a new impulse

Page 14: Cardiac medications nursing review 2011

• Can produce a sustained abnormal circuit rhythm. Re-entry circuits are responsible for atrial flutter, most paroxysmal supraventricular tachycardia, and dangerous ventricular tachycardia.

Page 15: Cardiac medications nursing review 2011

• Conditions that increase automaticity include sympathetic nervous system stimulation and hypoxia

Page 16: Cardiac medications nursing review 2011

• Resulting heart rhythm depends on where the first signal begins– if in sinoatrial node, the rhythm remains normal

but rapid– if an ectopic focus, many types of dysrhythmia

may ensue.

Page 17: Cardiac medications nursing review 2011

Positive Inotropes• THE EFFECTS OF STIMULATING ADRENERGIC RECEPTORS• RECEPTOR SITE ACTION• alpha peripheral blood vessels vasoconstriction of

peripheral arterioles• beta 1 myocardium increased heart rate (chronotropic)• increased contraction force

(inotropic) inc. conduction • • (dromotropic)• beta 2 peripheral blood vessels vasodilation of

peripheral arterioles & veins

• bronchioles bronchodilation

Page 18: Cardiac medications nursing review 2011
Page 19: Cardiac medications nursing review 2011

ANTIARRHYTMICS (Vaughan Williams classification)

• Class I – Membrane-stabilizing agents• Class II – Beta-blocking agents• Class III – Increase time for cell to

repolarize• Class IV – Calcium Channel blockers

Page 20: Cardiac medications nursing review 2011

• Class I agents interfere with the sodium (Na+) channel.

• Class II agents are anti-sympathetic nervous system agents. Most agents in this class are beta blockers.

• Class III agents affect potassium (K+) efflux. • Class IV agents affect calcium channels and the

AV node. • Class V agents work by other or unknown

mechanisms.

Page 21: Cardiac medications nursing review 2011

Class I Antidysrhythmics: • slow rate of spontaneous depolarization of cardiac

cells, thus decreasing automaticity, increasing refractory period, & decreasing susceptibility to escape beats

• Prolong QT interval.• Widen QRS interval: decreased Na+ influx into the

cell decreases conduction velocity and lengthens the QRS interval)

• CLASS I-A (quinidine, procainamide, disopyramide)Not often used today

Page 22: Cardiac medications nursing review 2011

Class 1c

• Increases blockage of sodium channel • Encainide, Tombocor, Rythmol• severe ventricular dysrhythmias

Page 23: Cardiac medications nursing review 2011

Class I: Sodium channel blockers

• Disopyramide (Norpace)Flecainide Procainamide Propafenone (Rythmol)Quinidine Tocainide

Page 24: Cardiac medications nursing review 2011

Beta blockers• Decrease mortality in patients with myocardial

infarction– Decrease infarct size– Decrease ventricular dysrhytmias

• Slow progression of heart failure (HF) and prolong lifespan in patients with HF

• Used in treatment of coronary artery disease, heart failure (HF), & dysrhythmia

Page 25: Cardiac medications nursing review 2011

Class II Agents: Beta Blockers

• Blockage of beta-1 receptors causes– Decreased force of contraction (- inotrope)– Decreased heart rate (-chronotrope)– Slowed conduction (-dromotrope)

• These 3 mechanisms of action combine to decrease myocardial oxygen demand

• decrease cardiac workload & myocardial oxygen needs

• Treatment of supraventricular tachycardias. They decrease conduction through the AV node.

Page 26: Cardiac medications nursing review 2011

Side Effects• Angina• Fatigue, nightmares, & slow HR• Males may experience impotence• Patients with asthma or emphysema may not be able to tolerate beta blockers because of an increase in symptoms of shortness

of breath and wheezing• Depression• Weight gain• Assess for cough, fatigue, edema, and other symptoms of

HF• may mask hypoglycemia in diabetics; check blood glucose

frequently• Removed from blood during hemodialysis; hold dose

until treatment finished

Page 27: Cardiac medications nursing review 2011

Cardioselectivity

• Acebutolol Sectrol• Atenolol Tenormin• Esmolol Brevibloc• Metoprolol Lopressor

Page 28: Cardiac medications nursing review 2011

Non Cardioselectivity

• Propranolol Inderal• Labetalol normodyne, Trandate (alpha

properties as well)• Carteolol Cartrol• Nadolol Corgard• Pindolol Visken• Timolol Blocadren

Page 29: Cardiac medications nursing review 2011

Beta Blockers

• Atenolol • Metoprolol • Propranolol • Sotalol • Bisoprolol • Nadolol

Carvedilol Timolol Nadolol Betaxolol Pindolol Labetolol

Page 30: Cardiac medications nursing review 2011

Calcium Channel Blockers• Block movement of calcium into smooth

muscle cells in vessel walls– Calcium required for muscle contraction;

calcium channel blockers cause relaxation and dilatation of arteries

– By this mechanism, lower BP– Dilate the coronary arteries so also used in

treatment of angina

Page 31: Cardiac medications nursing review 2011

• Reduce cardiac contractility, PVR, & myocardial O2 needs. Effective on reentrant dysrhythmias that require AV nodal conduction for their continuation

• In contrast to beta blockers, they allow the body to retain adrenergic control of heart rate and contractility.

• Some have a slowing effect on the heart rate and are used in the treatment of arrhythmia

• Used in treatment of hypertension, arrhythmia, and angina

Page 32: Cardiac medications nursing review 2011

Uses

• Paroxysmal SVT, rate control for a-fib and flutter

• Dilate coronary arteries/decreases BP • Potentiates effects of digoxin• Change position slowly.

Page 33: Cardiac medications nursing review 2011

Side Effects• Usually go away within a few hours to a day or so and are not said to be

permanent once the medication has "washed out" of the system• Common side effects of these drugs include constipation, dizziness, and

weakness• Swelling of the feet and ankles• Excessive lowering of the blood pressure

– Most common with first dose– Change position slowly

• Rarely an excessively slow heart beat • Worsening of HF• Many calcium channel blockers come in an extended release or sustained

release preparation ( XL, SR) that is convenient for once a day dosing. These tablets should not be cut in half or crushed, as this would affect the rate of drug release into the bloodstream.

Page 34: Cardiac medications nursing review 2011

Diltiazem (Cardizem)

• Less negative inotropic activity than verapamil• Dilates the coronary arteries

• Treatment of supraventricular arrhythmias

• Oral diltiazem is effective in treatment of reentry tachycardia

Page 35: Cardiac medications nursing review 2011

• Adverse Effects: fewest adverse effects of this category of drugs Hypotension- AV Block if patient is on Beta Blocker therapy

• Verapamil (Calan, Isoptin): severe hypotension & bradycardia

Page 36: Cardiac medications nursing review 2011

Calcium Channel Blockers

• Drugs in this class include:

• Nifedipine • Diltiazem • Verapamil • Amlodipine

Felodipine Isradapine Nicardipene Nimodipine Bepridil

Page 37: Cardiac medications nursing review 2011

ACE Inhibitors (“pril”)

• Used to treat both hypertension and Acute Coronary Syndrome

• Inhibit conversion of angiotension I to angiotension II >>> block release of aldosterone >>> reducing sodium & water retention

Page 38: Cardiac medications nursing review 2011

ACE Inhibitors• Act to lower the blood pressure

– Dilate blood vessels– Help with cardiac emptying in HF

• Good for patients with heart failure by lowering the net resistance in the vascular bed, thereby facilitating the heart’s task of pumping blood.

Page 39: Cardiac medications nursing review 2011
Page 40: Cardiac medications nursing review 2011
Page 41: Cardiac medications nursing review 2011

Indications

• Mild to severe hypertension• Treatment of heart failure• Given within 48 hours of MI to

prevent ventricular remodeling & development of HF

• Increase survival rate after MI

Page 42: Cardiac medications nursing review 2011
Page 43: Cardiac medications nursing review 2011

Side Effects• Hypotension

– have person lie down for 3 hrs after first dose

– temporarily D/C diuretics when starting therapya

– avoid potassium supplements/salt substitutes, diuretics (may cause severe hypotension)

• Hyperkalemia, renal tubular damage

• Cough• Angioedema

Page 44: Cardiac medications nursing review 2011

• Give one hour before meals• Hold enalapril or lisinopril until after

hemodialysis (both are removed by dialysis)

Page 45: Cardiac medications nursing review 2011

Ace Inhibitors

• Enalapril Vasotec• Lisinopril Zestril• Captopril Capoten• Quinapril Accupril• Benazopril • Fosinopril

Page 46: Cardiac medications nursing review 2011

ARBs• Related to ACE inhibitors• Used to treat hypertension• Block the action of angiotensin II to constrict

blood vessels– lower blood pressure– function in a similar way as the ACE

inhibitors, but do not cause the dry, hacking cough that is sometimes associated with ACE inhibitor use.

Page 47: Cardiac medications nursing review 2011
Page 48: Cardiac medications nursing review 2011

Angiotensin II Receptor Blockers (ARBs)

• Losartan • Valsartan • Candesartan • Irbesartan

Page 49: Cardiac medications nursing review 2011

Digitalis • First medication useful in treating

disorders of the heartbeat (1800s)• Digitalis leaf from the foxglove plant• Used to treat atrial fibrillation and heart

failure

Page 50: Cardiac medications nursing review 2011

Actions• Direct: increases myocardial contractility and CO

– Vagal effect on SA & AV nodes so decreases heart rate– Slows conduction through AV node (positive inotrope, negative

chronotrope and negative dromotrope)

• Indirect– decreases diastolic cardiac size– reduces cardiac wall tension– increases renal Na+ & H2O excretion– decreases peripheral vasoconstriction

Page 51: Cardiac medications nursing review 2011

• Slows HR so used in treatment of atrial fibrillation and atrial flutter– does not suppress or prevent arrhythmias

but only works to slow them down and relieve symptoms

of palpitations• Frequently used in heart failure (HF)

– Reduces frequency of HF exacerbations – Does not reduce mortality from HF

Page 52: Cardiac medications nursing review 2011

Digitalis Toxicity– anorexia, n & v, visual disturbances– lethargy, bradycardia, heart block,

tachydysrhythmias– Take apical heart rate for one full minute before

administering – Monitor digoxin levels: narrow therapeutic

window: 0.8-2.0 ng/ml– Monitor potassium levels: hypokalemia more

likely to become digtoxic

Page 53: Cardiac medications nursing review 2011

Drug Interactions

• Decreased digoxin absorption with antacids & laxatives

• Decreased digoxin effect: metoclopramide, aminoglycosides, thyroid supplements

• Increased digoxin effect Amphotericin B, corticosteroids, non-potassium-sparing diuretics, amiodarone

Page 54: Cardiac medications nursing review 2011

Digoxin Fab (Digibind)• Used for life-threatening digoxin toxicity

• Mechanism: antibody complex formation to digoxin

• Adverse Events– exacerbation of heart failure or a-fib due to withdrawal of

digoxin– potential for complex dissociation with repeat toxicity in end-

stage renal disease– digoxin levels meaningless for 7 days post Digibind use.

Page 55: Cardiac medications nursing review 2011

Nitrates

• Vasodilator: increases coronary blood flow by dilating coronary arteries and improving blood flow to ischemic regions of the heart– Decreases preload by dilating peripheral veins– Decreases afterload– Decreases myocardial oxygen demand to decrease

angina

Page 56: Cardiac medications nursing review 2011
Page 57: Cardiac medications nursing review 2011

• Used for angina, hypertension, MI• Used in heart failure to diminish symptoms

of shortness of breath• Do not reduce mortality in coronary artery

disease or heart failure. Their use is principally for symptom relief.

Page 58: Cardiac medications nursing review 2011

Short-acting: Nitroglycerin

• For acute anginal attacks. SL dosage (0.4mg):· Instruct patient to lie down· Repeat at 5 minute intervals; if pain not

relieved, up to 3 tablets· If anginal pain persists after 3 doses, go to ED· Stay with patient and monitor VS (esp. BP)· Headache & hypotension are major side effects

Page 59: Cardiac medications nursing review 2011

Long-acting Nitrates: Isordil, nitroglycerin ointment, nitroglycerin

transdermal patch

• Ointment: use appropriate application paper; don’t “rub in”

• Rotate sites (remove old patch, ointments)

• Avoid contact with skin

Nitrate-free periods (6 – 10 hrs/ 24 hr period) to prevent tolerance

Remove patch before defibrillating as patch may explode

Page 60: Cardiac medications nursing review 2011

Side Effects

• Hypotension, diaphoresis, nausea• Tachy- and bradydysrhythmias• Headache; reflex tachycardia

Page 61: Cardiac medications nursing review 2011

Drug Interactions

• Sympathomimetics, thyroid hormones, nicotine

• All increase cardiac workload so counteract NTG effects

Page 62: Cardiac medications nursing review 2011

Nitrates

• Drugs in this class include: • Isosorbide Dinitrate • Isosorbide Mononitrate

Page 63: Cardiac medications nursing review 2011

Amiodarone• Principal effect on cardiac tissue to increase time for cell to repolarize • Mainly block potassium channels, thereby prolonging

repolarization.• Do not affect the sodium channel so conduction velocity is

not decreased• Used to treat atrial arrhythmias (atrial fibrillation and atrial

flutter) as well as ventricular arrhythmias (ventricular fibrillation

• Prevent re-entrant arrhythmias• results in "chemical antifibrillatory" action

Page 64: Cardiac medications nursing review 2011

Side Effects

• Pulmonary fibrosis• Abnormal thyroid function• Photophobia,• Nausea, vomiting• Blue-gray skin color• Seeing halos around objects

Page 65: Cardiac medications nursing review 2011

• May take over 3 weeks to work; half-life about 50 days

• Monitor with patients in HF and elderly for decreased BP and pulse

• Assess for fluid retention

Page 68: Cardiac medications nursing review 2011

Class III — Potassium Channel Blockers

• Amiodarone (Cordarone)

• Dofetilide (Tikosyn)

• Ibutilide (Corvert)

Page 69: Cardiac medications nursing review 2011

So How Does This Relate to My Patients? HTN

• Goal – Two primary regulatory factors

• Blood flow (volume) • Peripheral Vascular Resistance (PVR)

– Primary groups of drugs are used: • Diuretics • Adrenergic inhibitors (Beta-blockers) • Vasodilators • ACE inhibitors

• Calcium antagonists

Page 70: Cardiac medications nursing review 2011

Pharmacologic Treatment

• For patients with systolic dysfunction (ejection fraction <40%) – Angiotensin-converting enzyme (ACE) inhibitors

for all patients – Beta blockers for all patients except

• Hemodynamic instability or• Dyspnea at rest with signs of

congestion

Page 71: Cardiac medications nursing review 2011

–Aldosterone antagonist (ACE inhibitor or ARB) for those with• dyspnea at rest or• symptomatic patients who have suffered

a recent myocardial infarction • ARB as a substitute for patients intolerant

of ACE inhibitors

Page 72: Cardiac medications nursing review 2011

• Digoxin only for patients who remain symptomatic despite treatment with– Diuretics, ACE inhibitors, and beta blockers– or for those in atrial fibrillation – Diuretics for symptomatic patients to maintain

appropriate fluid balance .

Page 73: Cardiac medications nursing review 2011

• HF patients on multiple medications are at a risk of potential drug interactions and side effects– risk of hyperkalemia is increased with renal

insufficiency treated with an aldosterone antagonist and an ACE inhibitor.

Page 74: Cardiac medications nursing review 2011

Goals for Mgt of Heart Disease

• Maximize blood flow to heart muscle • Maximize preload & minimize afterload • Maximize cardiac contractility (inotropic

effect)

Page 76: Cardiac medications nursing review 2011

What Drugs Help to Meet these Goals?

• Maximize preload I.V. fluids, volume expanders

• Minimize afterloadACE inhibitors • Maximize cardiac contractility Digoxin, Dopamine • Decrease preload, inc coronary circulation & reduce pulmonary congestion Nitrates

Page 77: Cardiac medications nursing review 2011

What Drugs Help to Meet these Goals (cont’d)?

• Reduce chances of ASA or other anti-platelet clot formation agents • Reduce fluid volume overload Diuretics

• Keep heart rate btw Beta blockers & 60-80/min Calcium-channel blockers • Dysrhythmias Antidysrhytmics

Page 78: Cardiac medications nursing review 2011

Treatment Goals for HF

– Relieve symptoms & improve quality of life – Prevent readmission to hospital, and/or recurrent

ischemic events – Reduce mortality – Medications used:

• ACE Inhibitors • Beta Blockers • Diuretics • Vasodilators • Digitalis

Page 79: Cardiac medications nursing review 2011

ACE Inhibitors

• Increase lifespan of patients with heart failure

• Effects on blood vessels that seem to counteract the process of atherosclerosis and have been shown to reduce heart attack, stroke, and mortality in CAD

Page 80: Cardiac medications nursing review 2011

Beta-Blockers

• Lower blood pressure & slow heart rate (including protection against arrhythmias)

• Helps lower risk of stroke and heart attacks

Page 81: Cardiac medications nursing review 2011

Nitrates

• Used to treat angina • Vasodilates and

stops chest pain by increasing myocardial oxygen supply & decreasing demand

Page 82: Cardiac medications nursing review 2011

Antidysrhythmic Drugs

• Used to bring under control abnormal rhythms of the heart (including atrial fibrillation), so the heart can pump more effectively

Page 83: Cardiac medications nursing review 2011

Antihypertensives

• Used to control BP & risk of stroke & MI• Categories

– ACE Inhibitors– Beta-Blockers– Calcium-Channel Blockers

Page 84: Cardiac medications nursing review 2011

Managing the Cost

• Patients may be taking two to four drugs to

manage cardiac condition – in addition to meds for other health

issues such as diabetes

– Med treatment for a chronic condition becomes expensive with each drug added

Page 85: Cardiac medications nursing review 2011

• Even with worsening condition some people try to limit costs– May or may not ask which can be decreased or

stopped

• Best if medication regimen is kept simple so patients without insurance can purchase generic versions without rationing their doses.

Page 86: Cardiac medications nursing review 2011

Refill Red Tape

• Patients and HCPs often face red tape when it comes to refills and preapproved status.

• If desired med is not on insurance company's preferred list– Must complete preauthorization form– Also must talk with insurance company about why

that particular medication is needed

Page 87: Cardiac medications nursing review 2011

• Patients receiving non-formulary drugs often pay more– May only be able to get partially filled

prescriptions– Providers should seek generic or less

expensive alternatives whenever possible

Page 88: Cardiac medications nursing review 2011
Page 89: Cardiac medications nursing review 2011

Simple Steps: Lifestyle Changes

• Decrease sodium intake

• Exercise & weight loss

Page 90: Cardiac medications nursing review 2011

Preload or Afterload?Arterial vasoconstriction

BP 190/124

Administration of hydralazine or nitroprusside

Administration of Nitroglycerin

Diuretic therapy

Arterial vasodilation

Page 91: Cardiac medications nursing review 2011

• List some positive and negative aspects to the administration of beta blockers

Page 92: Cardiac medications nursing review 2011

• The desired effect from the use of diuretics in the patient with acute left ventricular failure is to …

Page 93: Cardiac medications nursing review 2011

• List some medications that decrease myocardial contractility

Page 94: Cardiac medications nursing review 2011

• What are some of the signs & symptoms of left sided heart failure?

Page 95: Cardiac medications nursing review 2011

• Your patient on digoxin has a morning heart rate of 56 BPM and is supposed to be discharged today. Your first priority is to…

Page 96: Cardiac medications nursing review 2011

• What are some positive and negative aspects related to Nitroglycerin administration?

Page 97: Cardiac medications nursing review 2011

A patient with a dysrhythmia is placed on digoxin and metoprolol (Lopressor). Because of the combined effects of these drugs, what area(s) need to be the most closely monitored?